VIRGINIA LEWIS: Open Payments
NPI 1518323427 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 28 payments from 10 companies in 2025. Trend: 2023 $419 · 2024 $658 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $291 |
| Vanda Pharmaceuticals Inc. | 6 | $259 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $130 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| Neurocrine BioSciences, Inc. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Alkermes, Inc. | 2 | $43 |
| Lundbeck LLC | 2 | $42 |
| ABBVIE INC. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: FANAPT, ABILIFY MAINTENA, CAPLYTA, INVEGA SUSTENNA, INGREZZA, REXULTI, AUSTEDO XR, ARISTADA.
Industry payments across MS — which companies pay providers there.
